National Proton Conference 2026 to spotlight advances in particle therapy
Published: 13 Mar 2026
Author: Precedence Research
The National Association for Proton Therapy announced that the 2026 National Proton Conference will take place from March 18 to March 21 2026, in Nashville, Tennessee, United States. The annual conference is considered one of the key global meetings dedicated to proton and particle therapy, bringing together specialists from across the radiation oncology community to exchange insights on emerging clinical evidence, treatment technologies, and strategies to expand patient access to advanced cancer therapies. The conference is expected to draw a broad range of participants, including radiation oncologist medical physicist dosimetrists, healthcare administrators, researchers and industry representatives involved in the development and delivery of proton therapy systems.
Over the course of a four-day program, speakers from leading cancer centers will present recent findings on the clinical effectiveness of proton therapy, particularly in treating complex tumors where precise radiation targeting can help minimize damage to surrounding healthy tissues. Discussions will focus on treatment outcomes, patient quality of life, and the role of proton therapy in managing pediatric cancers, brain tumors and other difficult-to-treat malignancies. In addition to scientific presentations, the event will feature panel discussions addressing practical challenges faced by therapy centers. These sessions will explore topics such as operational efficiency, treatment planning optimization and the evolving reimbursement landscape for advanced radiation therapies.
According to Precedence Research, the particle therapy market size accounted for USD 1.86 billion in 2025 and is predicted to increase from USD 2.00 billion in 2026 to approximately USD 3.92 billion by 2035, expanding at a CAGR of 7.75% from 2026 to 2035 as demand grows for faster, scalable particle therapy.
Experts will also examine how hospitals and health systems can improve access to protein therapy for large patient population specially as demand for precision oncology treatments continues to rise. A dedicated industry exhibition will run alongside the scientific program, allowing companies involved in particle therapy technologies to showcase their latest innovations. Equipment manufacturers and technology developers are expected to present advancements in beam delivery systems imaging integration treatment planning software and facility design.
These technologies play an important role in improving treatment precision and enhancing workflow efficiency in proton therapy centers. The conference will also provide opportunities for networking and collaboration among clinicians, researchers, and technology providers workshops are educational sessions are planned to support knowledge sharing and professional training in areas such as dosimetry, radiation safety and proton therapy treatment protocols.
Such initiatives are increasingly viewed as essential for addressing the shortage of trained professionals in the field. Overall, the announcement of the 2026 National Proton Conference highlights the continued momentum in the particle therapy sector. As more healthcare institutions invest in proton therapy infrastructure, the clinical research expands. Events like this serve as an important platform for sharing evidence, strengthening partnerships and advancing the adoption of precision radiation therapies in cancer care.
This conference will focus on research innovation and wider access to proton therapy worldwide